EUVIMEDEUVIMED entdecken
Multizentrische Studie

Risk-Adapted Starting Age of Personalized Lung Cancer Screening

Chenran Wang, Xuesi Dong, Fengwei Tan, Zheng Wu, Yufei Huang, Yadi Zheng, Zilin Luo, Yongjie Xu, Liang Zhao, Jibin Li, Kaiyong Zou, Wei Cao und 6 weitere

CHEST · 2024

DOI: 10.1016/j.chest.2024.01.031 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift CHEST, 2024. Verfasst von Chenran Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences …. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The current one-size-fits-all screening strategy for lung cancer is not suitable for personalized screening. RESEARCH QUESTION: What is the risk-adapted starting age of lung cancer screening with comprehensive consideration of risk factors? STUDY DESIGN AND METHODS: The National Lung Cancer Screening program, a multicenter, population-based, prospective cohort study, was analyzed. Information on risk factor exposure was collected during the baseline risk assessment. A Cox proportional hazards model was used to estimate the association between risk factors and lung cancer incidence. Age-specific 10-year cumulative risk was calculated to determine the age at which individuals with various risk factors reached the equivalent risk level as individuals aged ≥ 50 years with active tobacco use and a ≥ 20 pack-year smoking history. RESULTS: Of the 1,031,911 participants enrolled in this study, 3,908 demonstrated lung cancer after a median follow-up of 3.8 years. We identified seven risk factors for lung cancer, including pack-years of smoking, secondhand smoke exposure, family history of lung cancer in first-degree relatives, history of respiratory diseases, occupational hazardous exposure, BMI, and diabetes. The 10-year cumulative risk of lung cancer for people aged ≥ 50 years with active tobacco use and a ≥ 20 pack-year smoking history was 1.37%, which was treated as the risk threshold for screening. Individuals who never smoked and those with active tobacco use and a < 30-pack-year history of smoking reached the equivalent risk level 1 to 14 years later compared with the starting age of 50 years. Men with active tobacco use, a ≥ 30-pack-year history of smoking, and concurrent respiratory diseases or diabetes should be screened 1 year earlier at the age of 49 years. INTERPRETATION: The personalized risk-adapted starting ages for lung cancer screening, based on the principle of equal management of equal risk, can served as an optimized screening strategy to identify high-risk individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEarly Detection of CancerHumansMaleMiddle AgedChinaFemaleProspective StudiesRisk FactorsAgedRisk AssessmentAge FactorsIncidenceMass ScreeningSmoking

Stichwörter der Autor:innen

lung cancerpersonalized screeningrisk factorsrisk-adapted screeningstarting age of screening

Autor:innen und Institutionen

  • Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
  • Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen.
  • Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing; Department of Epidemiology…

Förderung

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Zitieren

APA

Wang, C., Dong, X., Tan, F., Wu, Z., Huang, Y., Zheng, Y., Luo, Z., Xu, Y., Zhao, L., Li, J., Zou, K., Cao, W., Wang, F., Ren, J., Shi, J., Chen, W., He, J., & Li, N. (2024). Risk-Adapted Starting Age of Personalized Lung Cancer Screening. CHEST. https://doi.org/10.1016/j.chest.2024.01.031

Vancouver

Wang C, Dong X, Tan F, Wu Z, Huang Y, Zheng Y, et al. Risk-Adapted Starting Age of Personalized Lung Cancer Screening. CHEST. 2024. doi:10.1016/j.chest.2024.01.031

BibTeX
@article{Wang2024,
  author = {Wang, Chenran and Dong, Xuesi and Tan, Fengwei and Wu, Zheng and Huang, Yufei and Zheng, Yadi and Luo, Zilin and Xu, Yongjie and Zhao, Liang and Li, Jibin and Zou, Kaiyong and Cao, Wei and Wang, Fei and Ren, Jiansong and Shi, Jufang and Chen, Wanqing and He, Jie and Li, Ni},
  title = {Risk-Adapted Starting Age of Personalized Lung Cancer Screening},
  journal = {CHEST},
  year = {2024},
  doi = {10.1016/j.chest.2024.01.031}
}
Kostenlos starten →